The NCI-MATCH — Molecular Analysis for Therapy Choice investigates if targeted therapies for people whose tumors have specific gene mutations will be effective regardless of cancer type.
NCI-MPACT Trial — a clinical trial analyzing agents specific to certain tumor mutations regardless of tumor type. Learn more
Welcome to the Developmental Therapeutics Clinic
The National Cancer Institute (NCI) Developmental Therapeutics Clinic (DTC) focuses on providing outstanding clinical care for patients with advanced cancer as we work to develop new cancer treatments through innovative early-phase clinical trials. The DTC is part of the NCI, which is one of 27 institutes and centers that comprise the National Institutes of Health (NIH). It is the NCI clinic supporting the work of the Division of Cancer Treatment and Diagnosis (DCTD).
Each year, patients from around the world with cancers that have relapsed after treatment visit the DTC for consultation about participation in the innovative new treatment trials conducted at NIH. The DTC treats patients in NIH Clinical Center (for more information, please see the Clinical Center). Our patients are referred by other patients, patient’s physicians, families and friends, or personally may seek out these studies independently.
If you are a referring physician, patient, or family member, please contact us by email or phone.